<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04730362</url>
  </required_header>
  <id_info>
    <org_study_id>AP2007-50111</org_study_id>
    <nct_id>NCT04730362</nct_id>
  </id_info>
  <brief_title>Effect of Laryngeal Mask Airway on Image Quality n Pediatric Patients Undergoing Magnetic Resonant Imaging</brief_title>
  <official_title>Effect of Laryngeal Mask Airway on Image Quality n Pediatric Patients Undergoing Magnetic Resonant Imaging: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Institute, Egypt</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Institute, Egypt</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compare the effects of Oral airway vs LMA in preventing anesthesia-induced partial&#xD;
      airway obstruction, in an attempt to lessen MRI motion artifacts, which would result in&#xD;
      improvements in image quality.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Magnetic resonance image (MRI) is a frequently used imaging technique especially in&#xD;
      oncological patients, where it is used for diagnosis, following up response to treatment and&#xD;
      later for detection of possible recurrence. The main problem encountered with MRI is the long&#xD;
      time required for completion of the imaging, during which the patient is required to lie&#xD;
      still. Patients who are unable to lie still require sedation or general anesthesia (GA).&#xD;
      Almost all pediatric patients are uncooperative, making GA, the standard of care for&#xD;
      pediatric MRI.&#xD;
&#xD;
      Several general anesthetic techniques including airway management by endotracheal tube &amp;&#xD;
      various supraglottic devices (LMA) have been described. Choice of technique by&#xD;
      anesthesiologist is influenced by the patient's age, craniofacial and airway anatomy,&#xD;
      procedure duration, &amp; illness acuity.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">February 2021</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Control group : a Guedel oral airway will be inserted for airway management versus supraglottic group patients in which supraglottic airway laryngeal mask airway (LMA) will be used</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Randomization is done using computer generated sequence. Concealment will be achieved by opaque envelope</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Image quality of each MRI sequence</measure>
    <time_frame>During general anesthesia of MRI investigation procedure</time_frame>
    <description>Image quality of each MRI sequence is evaluated by using a scoring system with the following scores: score of 1 (non-diagnostic), score of 2 (poor quality but some diagnostic value), score of 3 (average), score of 4 (good), and score of 5 (excellent).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Airway Obstruction</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20 patients in which a Guedel oral airway will be inserted for airway management and to conduct inhalational anesthetic through face mask fixed with harness to the head and then connected to anesthesia breathing circuit of MRI compatible anesthesia machine for maintenance of anesthesia of O2 and sevoflurane 2-4% .</description>
  </arm_group>
  <arm_group>
    <arm_group_label>supraglottic group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20 patients in which supraglottic airway laryngeal mask airway (LMA) will be used and then connected to anesthesia breathing circuit of MRI compatible anesthesia machine for maintenance of anesthesia of O2 and sevoflurane 2-4% .</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>guedel airway</intervention_name>
    <description>Anesthesia will be conducted by induction with 1-2&#xD;
• Mg/kg of an IV propofol bolus and then anesthesia is maintained with an inhalational anesthesia with sevoflurane 2%-4%. The goal is to maintain the patient spontaneous ventilation throughout the procedure. Monitoring of the patients is done by MRI compatible pulse oximetry for heart rate and oxygen saturation which is connected to MRI control room.</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>supraglottic airway</intervention_name>
    <description>supraglottic airway</description>
    <arm_group_label>supraglottic group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propofol bolus and then anesthesia sevoflurane</intervention_name>
    <description>Mg/kg of an IV propofol bolus and then anesthesia is maintained with an inhalational anesthesia with sevoflurane 2%-4%</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>supraglottic group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ASA І and II patients&#xD;
&#xD;
          -  Age under 18 years .&#xD;
&#xD;
          -  The patient will need GA and patient Scheduled for MRI brain.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Glasgow coma scale ≤ 8&#xD;
&#xD;
          -  Emergency patient with full stomach.&#xD;
&#xD;
          -  Distorted upper airway anatomy making intubation with GA mandatory.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mohamed Abdel wadod, MD</last_name>
    <phone>+201006645981</phone>
    <email>m_wadod@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mai Rawas, Md</last_name>
    <phone>+201222177242</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Nataional Cancer Instituite</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>mohamed Abdel Wadod, MD</last_name>
      <phone>+201006645981</phone>
      <email>m_wadod@yahoo.coll</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 26, 2021</study_first_submitted>
  <study_first_submitted_qc>January 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2021</study_first_posted>
  <last_update_submitted>January 28, 2021</last_update_submitted>
  <last_update_submitted_qc>January 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cancer Institute, Egypt</investigator_affiliation>
    <investigator_full_name>Mohammed Abdelfattah Abdelwadod</investigator_full_name>
    <investigator_title>Mohammed Abdelfattah Abdelwadod</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Airway Obstruction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

